[SLRX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -203.75%
YoY- -283.49%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 0 0 0 0 0 0 -1,840 -
PBT -3,877 -5,341 -6,371 -14,409 -4,718 -6,109 -4,105 -3.74%
Tax -120 -80 111 -78 -38 -14 -44 95.56%
NP -3,877 -5,261 -6,482 -14,331 -4,718 -6,095 -4,105 -3.74%
Tax Rate - - - - - - - -
Total Cost 3,877 5,261 6,482 14,331 4,718 6,095 2,265 43.23%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 223.06 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -1.43 -2.20 -2.88 -6.38 -2.20 -3.29 -2.27 -26.57%
EPS Diluted -1.43 -2.20 -2.88 -6.38 -2.20 -3.29 -2.27 -26.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.